New

Asia Pacific Leukapheresis Market

2021

Asia Pacific Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

Publication Month: Nov 2021 | Report Code: TIPRE00025791 | No. of Pages: 137 | Category: Pharmaceuticals | Status: Published

Market Insights

Asia Pacific Leukapheresis Market to Grow at a CAGR of 9.6% to reach US$ 27.91 million Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The leukapheresis market in Asia Pacific is expected to grow from US$ 14.69 million in 2021 to US$ 27.91 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028.

The incidence of blood-related disorders is rising in developing countries due to the shift in lifestyle owing to the adoption of modern facilities. The modernization of facilities has led to reduction in physical activities of people, unlike stress levels, which are increasing due to various professional and personal factors. Developing countries are significantly focusing on the advancement of their healthcare facilities. For example, Hemophilia Federation India (HFI) is a nonprofit organization that has worked closely with the World Federation of Hemophilia (WFH) to spread awareness and educate people regarding affordable treatments available for hemophilia, thereby improving diagnosis and therapy. Thus, the abovementioned factors are providing opportunities for the growth of the leukapheresis market.

Countries in the Asia Pacific are facing challenges due to increasing incidences of COVID-19. The COVID-19 pandemic has put a major strain on the health systems of many countries around the world. The cases of COVID-19 in India, the pandemic caused by SARS-CoV-2, has reached to 10,582,647 and total deaths above 152,000 on January 19, 2021. There is currently no proven specific therapy, and multiple novel and repurposed molecules are being used on an experimental basis. The lack of effective therapeutic options has been a major hurdle in our pandemic mitigation measures. There are a few contender medicines including the malaria drug hydroxychloroquine, an antiviral Remdesivir, and Ivermectin, a drug used for worms and other parasites, but the results are not hugely encouraging and at times conflicting. In this backdrop, plasma therapy is being seen with interest as a cure for COVID-19 patients in India. Further, Medical equipment that carries out the apheresis procedure was installed at the GMCH at nearby Thrissur last month and the technique was used for the first time in Kerala to administer plasma to a 51-year old man. The apheresis procedure was carried out by GMC's technologists working with the departments of medicine, transfusion medicine and anesthesia.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific leukapheresis market. The Asia Pacific leukapheresis market is expected to grow at a good CAGR during the forecast period.
Asia Pacific leukapheresis market

Get more information on this report :


Asia Pacific Leukapheresis Market Segmentation

Asia Pacific Leukapheresis Market – By Product Type

  • Leukapheresis Disposables
  • Leukapheresis Devices

Asia Pacific Leukapheresis Market – By Application

  • Research Applications
  • Therapeutic Applications

Asia Pacific Leukapheresis Market – By Product Type

  • Blood Component Providers and Blood Centers
  • Hospitals and Transfusion Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes

Asia Pacific Leukapheresis Market – By Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of APAC
  • Canada
  • Mexico

Asia Pacific Leukapheresis Market – Companies Mentioned

  • Asahi Kasei Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • HemaCare
  • Macopharma
  • AllCells
  • STEMEXPRESS
  • BioIVT

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Leukapheresis Market – By Product Type

1.3.2 Asia Pacific Leukapheresis Market – By Application

1.3.3 Asia Pacific Leukapheresis Market – By End User

1.3.4 Asia Pacific Leukapheresis Market – By Country

2. Asia Pacific Leukapheresis Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Leukapheresis – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinions

5. Asia Pacific Leukapheresis Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Expanding Number of Voluntary Blood Donors

5.1.2 Up-Scaling Incidence of Hematologic Diseases

5.1.3 Growing Elderly Population

5.2 Key Market Restraints

5.2.1 Expensive Cost of Leukapheresis

5.3 Key Market Opportunities

5.3.1 Heighten opportunities in Emerging Economies

5.4 Future Trends

5.4.1 Expansion in Therapeutic Apheresis

5.5 Impact Analysis

6. Asia Pacific Leukapheresis – Market Analysis

6.1 Asia Pacific Leukapheresis Market Revenue Forecast and Analysis

7. Asia Pacific Leukapheresis Market Analysis – by Product Type

7.1 Overview

7.2 Asia Pacific Leukapheresis Market Share by Product Type 2021 & 2028 (%)

7.3 Leukapheresis Devices

7.3.1 Overview

7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Apheresis Devices

7.3.2.1.1 Overview

7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Leukapheresis ColuMillions and Cell Separators

7.3.2.2.1 Overview

7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Leukoreduction Filters

7.3.2.3.1 Overview

7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)

7.4 Leukapheresis Disposables

7.4.1 Overview

7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Leukapheresis Market Analysis – by Application

8.1 Overview

8.2 Asia Pacific Leukapheresis Market Share by Application 2021 & 2028 (%)

8.3 Research Applications

8.3.1 Overview

8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)

8.4 Therapeutic Applications

8.4.1 Overview

8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Leukapheresis Market Analysis – by End-User

9.1 Overview

9.2 Asia Pacific Leukapheresis Market Share by End-User 2021 & 2028 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)

9.4 Blood Component Providers and Blood Centers

9.4.1 Overview

9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)

9.6 Hospitals and Transfusion Centers

9.6.1 Overview

9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Leukapheresis Market – Country Analysis

10.1 Overview

10.1.2 Asia Pacific: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.1.2.1 China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Overview

10.1.2.1.2 China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3 China: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.2.1.3.1 China: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.2.1.4 China: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.2.1.5 China: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Overview

10.1.2.2.2 Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3 Japan: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.2.2.3.1 Japan: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.2.2.4 Japan: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.2.2.5 Japan: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 Overview

10.1.2.3.2 India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3 India: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.2.3.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.2.3.4 India: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.2.3.5 India: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.2.4 Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Overview

10.1.2.4.2 Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3 Australia: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.2.4.3.1 Australia: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.2.4.4 Australia: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.2.4.5 Australia: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.2.5 South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 Overview

10.1.2.5.2 South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.3 South Korea: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.2.5.3.1 South Korea: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.2.5.4 South Korea: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.2.5.5 South Korea: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Overview

10.1.2.6.2 Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.3 Rest of Asia Pacific: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.2.6.3.1 Rest of Asia Pacific: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.2.6.4 Rest of Asia Pacific: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.2.6.5 Rest of Asia Pacific: Leukapheresis Market, by End User, 2019–2028 (USD Million)

11. Asia Pacific Leukapheresis Market – Impact of COVID-19 Pandemic

11.1 Impact Assessment of COVID-19 Pandemic

12. Asia Pacific Leukapheresis Market – Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Asahi Kasei Corporation

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Fresenius SE & Co. KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Haemonetics Corporation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Terumo Corporation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 STEMCELL Technologies Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 HemaCare

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Macopharma

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 AllCells

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 STEMEXPRESS

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 BioIVT

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. China: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 2. China Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 3. China Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4. China: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5. Japan: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 6. Japan Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 7. Japan Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8. Japan: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. India: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 10. India Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 11. India Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12. India: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13. Australia: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 14. Australia Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 15. Australia Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Australia: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. South Korea: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 18. South Korea Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 19. South Korea Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20. South Korea: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Asia Pacific: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of Asia Pacific Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of Asia Pacific Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of Asia Pacific: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25. Organic Developments Done by Companies

Table 26. Inorganic Developments Done by Companies

Table 27. Glossary of Terms, Leukapheresis Market

LIST OF FIGURES

Figure 1. Asia Pacific Leukapheresis Market Segmentation

Figure 2. Asia Pacific Leukapheresis Market Segmentation, By country

Figure 3. Asia Pacific Leukapheresis Market Overview

Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market

Figure 5. China to Show Significant Growth During Forecast Period

Figure 6. Asia Pacific Leukapheresis Market, Industry Landscape

Figure 7. Asia Pacific PEST Analysis

Figure 8. Asia Pacific Leukapheresis market impact analysis of driver and restraints

Figure 9. Asia Pacific Leukapheresis Market – Revenue Forecast and Analysis to 2021-2028

Figure 10. Asia Pacific Leukapheresis Market Share by Product Type 2021 & 2028 (%)

Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Asia Pacific Leukapheresis Market Share by Application 2021 & 2028 (%)

Figure 18. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Asia Pacific Leukapheresis Market Share by End-User 2021 & 2028 (%)

Figure 21. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Asia Pacific: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 26. Asia Pacific: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 27. China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

  1. Asahi Kasei Corporation                                 
  2. Fresenius SE & Co. KGaA                                
  3. Haemonetics Corporation                              
  4. Terumo Corporation                                        
  5. STEMCELL Technologies Inc.                          
  6. HemaCare  
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS  
  10. BioIVT
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific leukapheresis market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025791
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.